Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients

Pediatric Transplantation

Volumn 7, Issue 2, 2003, Pages 125-129

  Feldstein, Ariel E ^a   Razonable, Raymund R ^a   Boyce, Thomas G ^a   Freese, Deborah K ^a   El Youssef, Mounif ^a   Perrault, Jean ^a   Paya, Carlos V ^a   Ishitani, Michael B ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cytomegalovirus; Human herpesvirus 6; Human herpesvirus 7; Pediatrics; Rejection

Indexed keywords

STEROID;

ADOLESCENT; ARTICLE; BLOOD TESTIS BARRIER; CASE REPORT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; FEVER; GRAFT REJECTION; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNOFLUORESCENCE; INFANT; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; MORBIDITY; PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; SEROLOGY; THROMBOCYTOPENIA;

ADOLESCENT; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GRAFT REJECTION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; INFANT; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 0347482473     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2003.00028.x     Document Type: Article

References (27)

1. SALAHUDDIN SZ, ABLASHI DV, MARKHAM PD, et al. Isolation of a new virus. HBLV, in patients with lymphoproliferative disorders. Science 1986: 234: 596-601.
2. FRENKEL N, SCHIRMER EC, WYATT IS. et al. Isolation of a new herpesvirus from human CD4 T cells. Proc Natl Acad Sci USA 1990: 87: 748-752.
3. GOMPELS UA, NICHOLAS J, LAWRENCE G, et al. The DNA sequence of human herpervirus-6: structure, coding content, and genome evolution. Virology 1995: 209: 29-51.
4. NICHOLAS J. Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J Virol 1996: 70: 5975-5989.
5. DOMINGUEZ G, DAMBAUGH TR, STARNEY FR, et al. Human herpesvirus 68 genome sequences: coding content and comparison with human herpesvirus 6A. J Virol 1999: 73: 8040-8052.
6. YOSHIKAWA T, SUGA S, ASANO Y, et al. Distribution of antibodies to a causative agent of exanthem subitum (HHV-6) in healthy individuals. Pediatrics 1989: 84: 675-677.
7. YAMANISHI K, OKUNO T, SHIRAKI K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988: 1: 1065-1069.
8. PRUKSANAMONDA P, HALL CB, INSEL RA, et al. Primary human herpesvirus 6 infection in young children. N Engl J Med 1992: 326: 1445-1450.
9. HALL CB, LONG CE, SCHNABEL KC, et al. Human herpesvirus-6 infection in children: a prospective study of complications and reactivation. N Engl J Med 1994: 331: 432-438.
10. SINGH N, CARRIGAN DR. Human herpesvirus 6 in transplantation: an emerging pathogen. Ann Inter Med 1996: 124: 1065-1071.
11. DROBYSKI WR, DUNNE WN, BURD EM, et al. Human herpesvirus 6 infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993: 167: 735-739.
12. CONE RW, HACKMAN RC, HUANG MLW, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993: 329: 156-161.
13. LAUTENCHLAGER I, HOCKERSTEDT K, LINNAVUORI K, TASKINEN E. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 1998: 26: 702-707.
14. HERBEIN G, STRASWIMMER J, ALTIERI M, et al. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Clin Infect Dis 1996: 22: 171-173.
15. GRIFFITHS PD, AIT-KHALED M, BEARCROFT CP, et al. Human herpesvirus 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol 1999: 59: 496-501.
16. SCHMIDT CA, WILBORN F, WEISS K, et al. A prospective study of human herpesvirus type 6 detected by PCR after liver transplantation. Transplantation 1996: 61: 662-664.
17. RAZONABLE RR, BROWN RA, RIVERO A, et al. Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV disease using two high throughput automated systems. J Clin Microbiol 2001: 39: 4472-4476.
18. DOCKRELL DH, PRADA J, JONES MF, et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 1997: 176: 1135-1140.
19. LJUNGMAN P, GRIFFITHS P, PAYA C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002: 34: 1094-1097.
20. LAUTENCHLAGER I, HOCKERSTEDT K, LINNAVUORI K, et al. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 1998: 26: 702-707.
21. ROGERS J, ROHAL S, CARRIGAN DR, et al. Human herpesvirus-6 in liver transplant recipients. Transplantation 2000: 69: 2566-2573.
22. MOSCHETINI D, DE MILITO A, CATUCCI M, et al. Detection of human herpesviruses 6 and 7 in heart transplant recipients by a multiplex polymerase chain reaction method. Eur J Clin Microbiol Infect Dis 1998: 17: 117-119.
23. RAZONABLE RR, BROWN RA, WILSON J, et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation 2002: 73: 968-973
24. KIDD IM, CLARK DA, SABIN CA, et al. Prospective study of human betaherpesviruses after renal transplantation. Transplantation 2000: 69: 2400-2004.
25. OKUNO T, HIGASHI K, SHIRAKI K, et al. Human herpesvirus 6 infection in renal transplantation. Transplantation 1990: 49: 519-522.
26. DESJARDIN JA, GIBBONS L, CHO E, et al. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J Infect Dis 1998: 178: 1783-1786.
27. CHAN PK, PEIRIS JS, YUEN KY, et al. Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients. J Med Virol 1997: 53: 295-305.